Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathway

28 Jul 2020

Abstract excerpt

Non-alcoholic fatty liver disease (NAFLD) has become the main cause of end-stage liver disease. Probiotics have the potential effect of alleviating NAFLD. The aim of this study was to explore functional probiotics and their underlying mechanisms. The bile salt hydrolase (BSH) activity in thirty-four strains was determined in vitro. Then, C57BL/6 mice were used to explore the effects of probiotics on NAFLD. Body...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diet, Metabolism, and Disease
Share to Drug Transport and Resistance Mechanisms
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32718371
DOI: 10.1017/s0007114520003001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 13 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lactobacillus casei YRL577 ameliorates markers of non-alcoholic fatty liver and alters expression of genes within the intestinal bile acid pathwayPMID 32718371Read ↗

The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat dietSemantic proximity Read ↗

Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeSemantic proximity Read ↗

Akkermansia muciniphila - A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation.Semantic proximity Read ↗

Cross-talk between bile acids and intestinal microbiota in host metabolism and healthSemantic proximity Read ↗

Lacticaseibacillus rhamnosus CCFM1060 Modulates gut microbiota and intestinal barrier Function: Alcoholic liver disease Mitigation through Nrf2/HO-1 and NF-κB PathwaysSemantic proximity Read ↗

Host ALDH2 deficiency aggravates nonalcoholic steatohepatitis through gut-liver axisSemantic proximity Read ↗

Discovery biomarker to optimize obeticholic acid treatment for non-alcoholic fatty liver diseaseSemantic proximity Read ↗

A gut microbial metabolite of linoleic acid ameliorates liver fibrosis by inhibiting TGF-β signaling in hepatic stellate cellsSemantic proximity Read ↗

The bsh1 gene of Lactobacillus plantarum AR113 ameliorates liver injury in colitis miceSemantic proximity Read ↗

Pregnane X receptor exacerbates nonalcoholic fatty liver disease accompanied by obesity- and inflammation-prone gut microbiome signatureSemantic proximity Read ↗

Study on intestinal survival and cholesterol metabolism of probioticsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.